Cargando…

Diagnostic performance of simplified TI-RADS for malignant thyroid nodules: comparison with 2017 ACR-TI-RADS and 2020 C-TI-RADS

BACKGROUND: The aim of this study is to propose a new TI-RADS and compare it with the American College of Radiology (2017 ACR)-TI-RADS and the 2020 Chinese (2020 C)-TI-RADS. METHODS: A retrospective analysis of 749 thyroid nodules was performed. Based on the calculated odds ratio of ultrasonic signs...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhiguang, Du, Yue, Cheng, Linggang, Zhang, Yukang, Zheng, Shuai, Li, Rui, Zhang, Wenkai, Zhang, Wei, He, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386958/
https://www.ncbi.nlm.nih.gov/pubmed/35978376
http://dx.doi.org/10.1186/s40644-022-00478-y
_version_ 1784769924473815040
author Chen, Zhiguang
Du, Yue
Cheng, Linggang
Zhang, Yukang
Zheng, Shuai
Li, Rui
Zhang, Wenkai
Zhang, Wei
He, Wen
author_facet Chen, Zhiguang
Du, Yue
Cheng, Linggang
Zhang, Yukang
Zheng, Shuai
Li, Rui
Zhang, Wenkai
Zhang, Wei
He, Wen
author_sort Chen, Zhiguang
collection PubMed
description BACKGROUND: The aim of this study is to propose a new TI-RADS and compare it with the American College of Radiology (2017 ACR)-TI-RADS and the 2020 Chinese (2020 C)-TI-RADS. METHODS: A retrospective analysis of 749 thyroid nodules was performed. Based on the calculated odds ratio of ultrasonic signs between benign and malignant nodules, a new thyroid nodule score and malignancy rate were calculated. A receiver operating characteristic curve was drawn to analyze the new system’s effectiveness in the differential diagnosis of benign and malignant thyroid nodules and was compared with the 2020 C-TI-RADS and 2017 ACR-TI-RADS. Five ultrasound physicians with different qualifications graded another 123 thyroid nodules according to the 2017ACR-TI-RADS, 2020 C-TI-RADS, and the newly proposed TI-RADS. Intergroup and intragroup consistency was evaluated using the Kappa test and intraclass correlation coefficient (ICC) test. RESULTS: 1) The new thyroid nodule score was divided into 0, 1, 2, 3, 4, and 5 points, with malignancy rates of 1.52%, 7.69%, 38.24%, 76.00%, 90.75%, and 93.75%, respectively. Using 3 points as the cutoff value to diagnose benign and malignant thyroid nodules, the sensitivity and specificity were 94.03% and 67.39%, respectively, which were higher than those of the 2017 ACR-TI-RADS and 2020 C-TI-RADS. The simplified TI-RADS, namely, sTI-RADS, was established as follows: sTI-RADS 3 (0 points), malignancy rate < 2%; sTI-RADS 4a (1 point), malignancy rate 2–10%; sTI-RADS 4b (2 points), malignancy rate 10–50%; sTI-RADS 4 (3 points), malignancy rate 50–90%; and sTI-RADS 5 (4 and 5 points), malignancy rate > 90%. 2) Five ultrasound doctors graded thyroid nodules by the 2017 ACR-TI-RADS, 2020C-TI-RADS and sTI-RADS. Intragroup consistency was good among all tests; ICC were 0.86 (0.82–0.90), 0.84 (0.78–0.88), and 0.88 (0.84–0.91), respectively, while only sTI-RADS had good intergroup consistency. CONCLUSION: In summary, we proposed a new TI-RADS, namely, sTI-RADS, which was obtained using a simple assignment method with higher specificity, accuracy, positive predictive value, and Youden index than the 2017 ACR-TI-RADS and 2020 C-TI-RADS.
format Online
Article
Text
id pubmed-9386958
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93869582022-08-19 Diagnostic performance of simplified TI-RADS for malignant thyroid nodules: comparison with 2017 ACR-TI-RADS and 2020 C-TI-RADS Chen, Zhiguang Du, Yue Cheng, Linggang Zhang, Yukang Zheng, Shuai Li, Rui Zhang, Wenkai Zhang, Wei He, Wen Cancer Imaging Research Article BACKGROUND: The aim of this study is to propose a new TI-RADS and compare it with the American College of Radiology (2017 ACR)-TI-RADS and the 2020 Chinese (2020 C)-TI-RADS. METHODS: A retrospective analysis of 749 thyroid nodules was performed. Based on the calculated odds ratio of ultrasonic signs between benign and malignant nodules, a new thyroid nodule score and malignancy rate were calculated. A receiver operating characteristic curve was drawn to analyze the new system’s effectiveness in the differential diagnosis of benign and malignant thyroid nodules and was compared with the 2020 C-TI-RADS and 2017 ACR-TI-RADS. Five ultrasound physicians with different qualifications graded another 123 thyroid nodules according to the 2017ACR-TI-RADS, 2020 C-TI-RADS, and the newly proposed TI-RADS. Intergroup and intragroup consistency was evaluated using the Kappa test and intraclass correlation coefficient (ICC) test. RESULTS: 1) The new thyroid nodule score was divided into 0, 1, 2, 3, 4, and 5 points, with malignancy rates of 1.52%, 7.69%, 38.24%, 76.00%, 90.75%, and 93.75%, respectively. Using 3 points as the cutoff value to diagnose benign and malignant thyroid nodules, the sensitivity and specificity were 94.03% and 67.39%, respectively, which were higher than those of the 2017 ACR-TI-RADS and 2020 C-TI-RADS. The simplified TI-RADS, namely, sTI-RADS, was established as follows: sTI-RADS 3 (0 points), malignancy rate < 2%; sTI-RADS 4a (1 point), malignancy rate 2–10%; sTI-RADS 4b (2 points), malignancy rate 10–50%; sTI-RADS 4 (3 points), malignancy rate 50–90%; and sTI-RADS 5 (4 and 5 points), malignancy rate > 90%. 2) Five ultrasound doctors graded thyroid nodules by the 2017 ACR-TI-RADS, 2020C-TI-RADS and sTI-RADS. Intragroup consistency was good among all tests; ICC were 0.86 (0.82–0.90), 0.84 (0.78–0.88), and 0.88 (0.84–0.91), respectively, while only sTI-RADS had good intergroup consistency. CONCLUSION: In summary, we proposed a new TI-RADS, namely, sTI-RADS, which was obtained using a simple assignment method with higher specificity, accuracy, positive predictive value, and Youden index than the 2017 ACR-TI-RADS and 2020 C-TI-RADS. BioMed Central 2022-08-17 /pmc/articles/PMC9386958/ /pubmed/35978376 http://dx.doi.org/10.1186/s40644-022-00478-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Chen, Zhiguang
Du, Yue
Cheng, Linggang
Zhang, Yukang
Zheng, Shuai
Li, Rui
Zhang, Wenkai
Zhang, Wei
He, Wen
Diagnostic performance of simplified TI-RADS for malignant thyroid nodules: comparison with 2017 ACR-TI-RADS and 2020 C-TI-RADS
title Diagnostic performance of simplified TI-RADS for malignant thyroid nodules: comparison with 2017 ACR-TI-RADS and 2020 C-TI-RADS
title_full Diagnostic performance of simplified TI-RADS for malignant thyroid nodules: comparison with 2017 ACR-TI-RADS and 2020 C-TI-RADS
title_fullStr Diagnostic performance of simplified TI-RADS for malignant thyroid nodules: comparison with 2017 ACR-TI-RADS and 2020 C-TI-RADS
title_full_unstemmed Diagnostic performance of simplified TI-RADS for malignant thyroid nodules: comparison with 2017 ACR-TI-RADS and 2020 C-TI-RADS
title_short Diagnostic performance of simplified TI-RADS for malignant thyroid nodules: comparison with 2017 ACR-TI-RADS and 2020 C-TI-RADS
title_sort diagnostic performance of simplified ti-rads for malignant thyroid nodules: comparison with 2017 acr-ti-rads and 2020 c-ti-rads
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386958/
https://www.ncbi.nlm.nih.gov/pubmed/35978376
http://dx.doi.org/10.1186/s40644-022-00478-y
work_keys_str_mv AT chenzhiguang diagnosticperformanceofsimplifiedtiradsformalignantthyroidnodulescomparisonwith2017acrtiradsand2020ctirads
AT duyue diagnosticperformanceofsimplifiedtiradsformalignantthyroidnodulescomparisonwith2017acrtiradsand2020ctirads
AT chenglinggang diagnosticperformanceofsimplifiedtiradsformalignantthyroidnodulescomparisonwith2017acrtiradsand2020ctirads
AT zhangyukang diagnosticperformanceofsimplifiedtiradsformalignantthyroidnodulescomparisonwith2017acrtiradsand2020ctirads
AT zhengshuai diagnosticperformanceofsimplifiedtiradsformalignantthyroidnodulescomparisonwith2017acrtiradsand2020ctirads
AT lirui diagnosticperformanceofsimplifiedtiradsformalignantthyroidnodulescomparisonwith2017acrtiradsand2020ctirads
AT zhangwenkai diagnosticperformanceofsimplifiedtiradsformalignantthyroidnodulescomparisonwith2017acrtiradsand2020ctirads
AT zhangwei diagnosticperformanceofsimplifiedtiradsformalignantthyroidnodulescomparisonwith2017acrtiradsand2020ctirads
AT hewen diagnosticperformanceofsimplifiedtiradsformalignantthyroidnodulescomparisonwith2017acrtiradsand2020ctirads